Not Tagged
Sana Biotechnology
[]
sana biotechnology highlights preclinical hypoimmune data for its allogeneic car t platform and advancements with its in vivo fusogen platform with four presentations at the 2023 aacr annual meeting 
Pharmaceutical News - Direct Information